News and Trends 5 May 2023Exothera partners with Quantoom and launches DNA business unit Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The… May 5, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 May 2023World’s first RSV vaccine for older adults gets FDA approval GSK plc says the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the… May 4, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by Quantoom Biosciences 4 May 2023How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production? Quantoom Biosciences has just launched Ntensify™, the world’s first continuous mRNA production technology that is set to revolutionize the entire… May 4, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 3 May 2023Immunotherapy in the fight against solid tumors Ever since William Coley first attempted to harness the immune system in 1891 to treat bone cancer, immunotherapy has been… May 3, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Apr 2023Vaccine for honeybees: a new hope for American foulbrood disease In the last few years, there has been an ongoing movement to ‘save the bees’, and the U.S. biotech Dalan… April 26, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 26 Apr 2023aVaxziPen’s needle-free vaccine yields positive data across multiple diseases aVaxziPen, a biotech company developing a novel needle-free vaccine delivery platform, presented data at the World Vaccine Congress (WVC) in… April 26, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 26 Apr 2023Global partners announce The Big Catch-up vaccination effort WHO, UNICEF, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation, along with Immunization Agenda 2030 and many… April 26, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 26 Apr 2023Can mRNA vaccines tackle multiple diseases? By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week… April 26, 2023 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 26 Apr 2023How to address declining vaccination rates in older adults By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last… April 26, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 26 Apr 202320Med Therapeutics and Touchlight collaborating on novel vaccine delivery platform 20Med Therapeutics, a company working on non-viral delivery and development of gene therapies and vaccines, and Touchlight, a biotechnology company… April 26, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 25 Apr 2023More efficient and cost-effective mRNA vaccines developed A new and patented method for the production of the important mRNA vaccine component pseudouridine is more efficient, sustainable and… April 25, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 19 Apr 2023How Vaccine Platforms Can Prepare Us for Future Pandemics The COVID-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be powerful tools for reacting faster to future… April 19, 2023 - 7 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
Expert Advice 18 Apr 2023Pharmacovigilance – how to deal with the data By Axel Hagel, practice leader, PV & RM services, IQVIA Life science data, especially safety data, is exploding. Axel Hagel,… April 18, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 17 Apr 2023Ghana becomes first country to approve University of Oxford malaria vaccine Ghana has granted full national licensure for the University of Oxford’s R21/Matrix-M malaria vaccine, marking the first regulatory clearance for… April 17, 2023 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 14 Apr 2023mRNA vaccines: a promising future In 1978, nearly two decades after the discovery of messenger RNA (mRNA), the concept of a vaccine made from mRNA… April 14, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Apr 2023Parkinson’s cure ‘inevitable’ after biomarker breakthrough The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced what it says is the ‘most significant breakthrough yet’… April 13, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 20236 new vaccines being developed for difficult-to-treat diseases There are several promising new vaccine candidates being developed for complex diseases that historically have been extremely difficult to find… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Apr 2023Is a vaccine for Parkinson’s disease possible? Finding a truly effective treatment for Parkinson’s disease - that goes beyond simply managing symptoms - has long been a… April 11, 2023 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Apr 2023Cancer vaccines: 10 biotech companies that have changed the game A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered… April 6, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Apr 2023Alzamend pushing ahead with Alzheimer’s vaccine trial Alzamend Neuro, Inc. has announced the initiation of a phase I/IIA clinical trial for its immunotherapy vaccine (ALZN002) to treat… April 4, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email